Cargando…
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey
The safety profile of COVID-19 vaccines is understudied in patients with systemic sclerosis (SSc). We compared short-term adverse events (AEs) 7 days following vaccination in patients with SSc vs other rheumatic (AIRDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs). The COV...
Autores principales: | Naveen, R., Thakare, Darpan R., Kuwana, Masataka, Pauling, John D., Day, Jessica, Joshi, Mrudula, Parodis, Ioannis, Sen, Parikshit, Jagtap, Kshitij, Nikiphorou, Elena, Saha, Sreoshy, Agarwal, Vishwesh, Chatterjee, Tulika, Lilleker, James B., Kardes, Sinan, Milchert, Marcin, Gheita, Tamer, Salim, Babur, Velikova, Tsvetelina, Gracia-Ramos, Abraham Edgar, Tan, Ai Lyn, Nune, Arvind, Cavagna, Lorenzo, Saavedra, Miguel A., Shinjo, Samuel Katsuyuki, Ziade, Nelly, Knitza, Johannes, Distler, Oliver, Chinoy, Hector, Aggarwal, Rohit, Gupta, Latika, Agarwal, Vikas, Makol, Ashima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064600/ https://www.ncbi.nlm.nih.gov/pubmed/37000295 http://dx.doi.org/10.1007/s00296-023-05310-9 |
Ejemplares similares
-
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
por: Sen, Parikshit, et al.
Publicado: (2021) -
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey
por: Grignaschi, Silvia, et al.
Publicado: (2023) -
COVAD survey 2 long-term outcomes: unmet need and protocol
por: Fazal, Zoha Zahid, et al.
Publicado: (2022) -
COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies
por: Gil‐Vila, Albert, et al.
Publicado: (2022) -
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
por: Hoff, Leonardo Santos, et al.
Publicado: (2022)